taltrimide has been researched along with Epilepsies, Myoclonic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Airaksinen, EM; Gothóni, G; Keränen, T; Koivisto, K; Marnela, KM; Oja, SS; Partanen, JV; Pitkänen, A; Riekkinen, PJ; Tokola, O | 1 |
1 trial(s) available for taltrimide and Epilepsies, Myoclonic
| Article | Year |
|---|---|
Biochemical and clinical studies on epileptic patients during two phase I trials with the novel anticonvulsant taltrimide.
Topics: Adult; Amino Acids; Anticonvulsants; Clinical Trials as Topic; Epilepsies, Myoclonic; Epilepsies, Partial; Female; Homovanillic Acid; Humans; Male; Phthalimides | 1987 |